Trials / Completed
CompletedNCT06479772
Evaluation of the Potential Impact of an Artificial Intelligence Solution in Second Reading of Organized Screening.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 55,589 (actual)
- Sponsor
- GCS Ramsay Santé pour l'Enseignement et la Recherche · Academic / Other
- Sex
- Female
- Age
- 50 Years – 74 Years
- Healthy volunteers
- Accepted
Summary
Based on data from a series of patients who underwent screening mammography with a "normal" or "benign" first-reading result. The main objective of the study is to evaluate the possibilities of subtracting from the second reading of breast cancer screening a population of examinations for which the risk of discovering cancer is close to zero, using an AI system (here the MammoScreen™ system).
Detailed description
This is a retrospective multicenter study of mammography imaging data contained in the PACS (Picture Archiving and Communication System) of six radiology centers located in the Rhône, Puy de dôme, Cantal and Haute-Loire départements. In order to be able to collect two-year follow-up data, the files analyzed will concern all women who received a screening mammogram during the years 2015, 2016, 2017, 2018 and 2019. More recent mammograms will be excluded.
Conditions
Timeline
- Start date
- 2023-10-10
- Primary completion
- 2024-03-31
- Completion
- 2024-03-31
- First posted
- 2024-06-28
- Last updated
- 2024-06-28
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06479772. Inclusion in this directory is not an endorsement.